Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Dec 10, 2018

Keywords

ClinConnect Summary

This clinical trial is studying a new device that can better evaluate how well the blood forms clots to stop bleeding. This is especially important for people with conditions like von Willebrand disease, those who have major bleeding disorders, or patients taking medications that affect platelets (the cells that help blood clot). The goal is to create a test that looks at blood flow in a way that more closely mimics how blood behaves in real-life situations, helping doctors understand the risk of bleeding for these patients.

To participate in the study, you need to be an adult who can give consent and either be a blood donor or a patient with one of the mentioned conditions. Participants will only need to provide a small amount of extra blood during routine tests. The study is currently looking for participants, and it's important to note that some people, like those without health insurance or pregnant individuals, cannot participate. This trial could lead to better testing methods and improved care for patients at risk of bleeding.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • person who has given oral consent
• • adult
• • blood donor at EFS Bourgogne Franche-Comté
• • or patient with von Willebrand disease or major constitutional thrombopathy followed by the Resource and Competence Centre (CRC) - Constitutional Hemorrhagic Diseases of Dijon or Besançon
• • or patient on antiplatelet drugs consulting for thrombosis at the Dijon Bourgogne or Besançon Hospital
• Exclusion Criteria:
• • a person who is not affiliated to or not a beneficiary of national health insurance
• • person subject to court-ordered protection (curatorship, guardianship)
• • pregnant, parturient or breastfeeding woman
• • a person who is unable to consent
• • person on anti-inflammatory treatment and serotonin reuptake inhibitor antidepressants (platelet function disorders)